AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Here’s the takeaway: options data and news align for a bullish bias, but technicals hint at short-term caution. Let’s break it down.
Bullish Sentiment in Options, But Watch the RSIBRK.B’s options chain tells a story. This Friday’s top OTM calls ($500, $505, $510) have combined OI of 39,567 contracts—nearly double the top puts ($490, $480) at 15,354. That’s a clear tilt toward buyers expecting a rally. The put/call ratio of 0.53 (call-heavy) reinforces this. But here’s the catch: RSI at 36 suggests oversold conditions, and MACD (-1.45) remains bearish. The market isn’t all-in on a breakout—yet. Traders are hedging their bets, with heavy put OI at $490 acting as a safety net if the stock stumbles.
Abel’s Takeover and OxyChem Add Fuel to the FireGreg Abel’s CEO transition isn’t just a name change. He’s a Buffett protégé with a knack for operational tweaks—think efficiency upgrades at subsidiaries. The $9.7B OxyChem acquisition? A strategic move to diversify into industrial chemicals, a sector with steady demand. Combine that with $380B in cash, and you’ve got a CEO with both a safety net and a slingshot. Retail investors are betting on Abel’s "active management" to unlock value, which explains the call buying. But don’t ignore the puts: if Abel’s early moves underwhelm, the stock could test $490 support.
Trade Ideas: Calls for Gains, Puts for ProtectionFor options players, the BRK. call (expiring Jan 23) is a standout. With OI at 4,371, it’s the most liquid next-week strike. Why? The $500 level is just below the 30D MA (499.68), and a close above it could trigger a rebound. For a conservative play, pair it with a BRK. put (OI: 1,771) to cap downside risk.
Stock traders: Watch the Bollinger Bands. If BRK.B holds above the lower band ($492.15), consider entries near $492.50 with a target at $500. A break above the 200D MA ($496.49) would validate the bullish case. But if RSI fails to climb above 40, tighten stops to $490.
Volatility on the HorizonAbel’s active management and OxyChem’s integration could drive near-term moves, but technicals suggest a bumpy start. The key is balancing optimism with discipline—calls offer upside, but don’t ignore the puts. This isn’t a straight-line trade. It’s a dance between Abel’s operational edge and market skepticism. Stay nimble, and let the data guide your next move.

Focus on daily option trades

Jan.16 2026

Jan.16 2026

Jan.16 2026

Jan.16 2026

Jan.16 2026
Unlock Market-Moving Insights.
Subscribe to PRO Articles.
Already have an account? Sign in
Unlock Market-Moving Insights.
Subscribe to PRO Articles.
Already have an account? Sign in
Daily stocks & crypto headlines, free to your inbox